Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:epoetin_alfa
|
| gptkbp:administeredBy |
injection
|
| gptkbp:approvedBy |
gptkb:FDA
1989 |
| gptkbp:ATCCode |
B03XA01
|
| gptkbp:brand |
gptkb:epoetin_alfa
|
| gptkbp:contraindication |
uncontrolled hypertension
pure red cell aplasia |
| gptkbp:form |
solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Procrit
|
| gptkbp:indication |
reduce need for red blood cell transfusions
anemia in HIV-infected patients treated with zidovudine |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Janssen_Pharmaceuticals
|
| gptkbp:mechanismOfAction |
stimulates erythropoiesis
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:relatedTo |
gptkb:darbepoetin_alfa
gptkb:Epogen |
| gptkbp:routeOfAdministration |
subcutaneous
intravenous |
| gptkbp:sideEffect |
fever
nausea headache hypertension joint pain |
| gptkbp:storage |
2-8°C
|
| gptkbp:usedFor |
gptkb:anemia
anemia due to chronic kidney disease anemia due to chemotherapy |
| gptkbp:bfsParent |
gptkb:Janssen_Biotech
|
| gptkbp:bfsLayer |
6
|